republic-os/legislation/us/states/fl/2023/sb-1352.md

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, chapter_law, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags

type	title	description	jurisdiction	legislature	session	identifier	citation	classification	subjects	status	chapter_law	primary_sponsors	version_count	action_count	vote_count	first_action	last_action	source	source_identifier	source_url	source_hash	vintage	source_snapshot	retrieved_at	confidence	tags
Bill	Sickle Cell Disease Medications, Treatment, and Screening	Sickle Cell Disease Medications, Treatment, and Screening; Requiring newborn and infant screening providers to notify primary care physicians of newborns and infants of certain screening results and to submit the results to the Department of Health for a specified purpose; requiring the department to contract with a certain center to establish and maintain a sickle cell registry; authorizing parents and guardians of children in the registry to request to have them removed from the registry; requiring the Agency for Health Care Administration, in consultation with certain entities, to review sickle cell disease medications, treatments, and services for Medicaid recipients and develop a written report, post the report on its website, and submit a copy of the report to the Governor, the Legislature, and certain entities by a specified date and every 2 years thereafter, etc.	us/states/fl	Florida Legislature	2023	SB 1352	Florida SB 1352 (2023)	bill		enacted	2023-258	Fiscal Policy Rouson	5	34	5	2023-03-01	2023-06-20	openstates	ocd-bill/cb33b47f-c3a7-40df-ba84-4a94e9284dfe	https://flsenate.gov/Session/Bill/2023/1352/ByCategory	523806ebc912236d80c07464e9e73a93aae121b6148e10bfb72fb31e86c5e880	2026-07-01	https://data.openstates.org/daily/2026-07-01/public.pgdump	2026-07-06	reported	legislation bill us-fl

Florida SB 1352 (2023) — Sickle Cell Disease Medications, Treatment, and Screening

Sickle Cell Disease Medications, Treatment, and Screening; Requiring newborn and infant screening providers to notify primary care physicians of newborns and infants of certain screening results and to submit the results to the Department of Health for a specified purpose; requiring the department to contract with a certain center to establish and maintain a sickle cell registry; authorizing parents and guardians of children in the registry to request to have them removed from the registry; requiring the Agency for Health Care Administration, in consultation with certain entities, to review sickle cell disease medications, treatments, and services for Medicaid recipients and develop a written report, post the report on its website, and submit a copy of the report to the Governor, the Legislature, and certain entities by a specified date and every 2 years thereafter, etc.

Enacted — Laws of Florida, Chapter 2023-258.

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

1. S 1352 Filed (filed) — source
2. S 1352 c1 (committee substitute) — source
3. S 1352 c2 (committee substitute) — source
4. S 1352 e1 (engrossed) — source
5. S 1352 er (enrolled) — source

Votes

• Favorable — 12–0 (pass) · upper
• Favorable with Committee Substitute — 20–0 (pass) · upper
• Third Reading — 40–0 (pass) · upper
• Passage, Third Reading — 116–0 (pass) · lower
• Favorable with Committee Substitute — 16–0 (pass) · upper

Sponsors

• Appropriations Committee on Health and Human Services — primary (organization)
• Fiscal Policy — primary (person)
• Rouson — primary (person)
• Davis — cosponsor (person)

Timeline

The legislative action history — every referral, reading, and vote.

• 2023-03-01 Filed filing
• 2023-03-06 Referred to Health Policy; Appropriations Committee on Health and Human Services; Fiscal Policy referral-committee
• 2023-03-07 Introduced introduction
• 2023-03-30 On Committee agenda-- Health Policy, 04/04/23, 8:30 am, 412 Knott Building
• 2023-04-04 Favorable by Health Policy; YEAS 12 NAYS 0 committee-passage-favorable
• 2023-04-04 Now in Appropriations Committee on Health and Human Services
• 2023-04-06 On Committee agenda-- Appropriations Committee on Health and Human Services, 04/12/23, 8:30 am, 412 Knott Building
• 2023-04-12 CS by Appropriations Committee on Health and Human Services; YEAS 16 NAYS 0
• 2023-04-14 Pending reference review under Rule 4.7(2) - (Committee Substitute)
• 2023-04-14 Now in Fiscal Policy
• 2023-04-17 On Committee agenda-- Fiscal Policy, 04/20/23, 9:30 am, 412 Knott Building
• 2023-04-17 CS by Appropriations Committee on Health and Human Services read 1st time
• 2023-04-20 CS/CS by- Fiscal Policy; YEAS 20 NAYS 0
• 2023-04-24 Pending reference review -under Rule 4.7(2) - (Committee Substitute)
• 2023-04-24 Placed on Calendar, on 2nd reading
• 2023-04-24 Placed on Special Order Calendar, 04/26/23
• 2023-04-25 CS/CS by Fiscal Policy read 1st time
• 2023-04-26 Read 2nd time reading-2
• 2023-04-26 Amendment(s) adopted (306086)
• 2023-04-26 Read 3rd time reading-3
• 2023-04-26 CS passed as amended; YEAS 40 NAYS 0 passage
• 2023-04-26 In Messages
• 2023-05-01 Bill referred to House Calendar
• 2023-05-01 Bill added to Special Order Calendar (5/2/2023)
• 2023-05-01 1st Reading (Engrossed 1) reading-1
• 2023-05-02 Read 2nd time reading-2
• 2023-05-02 Placed on 3rd reading reading-3
• 2023-05-02 Added to Third Reading Calendar
• 2023-05-03 Read 3rd time reading-3
• 2023-05-03 CS passed; YEAS 116, NAYS 0 passage
• 2023-05-03 Ordered enrolled enrolled
• 2023-06-12 Signed by Officers and presented to Governor executive-receipt
• 2023-06-19 Approved by Governor executive-signature
• 2023-06-20 Chapter No. 2023-258

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/cb33b47f-c3a7-40df-ba84-4a94e9284dfe. Confidence: reported (aggregated from official Florida legislature records).